Literature DB >> 10171166

Revival of the Ugandan Blood Transfusion System 1989: an example of international cooperation.

E J Watson-Williams1, P K Kataaha.   

Abstract

10 yr of civil war in Uganda had destroyed the Blood Transfusion Service when the government came to power in 1986. AIDS had become recognized as a problem of severe proportion. In 1987, the E.E.C. pledged to rehabilitate the central blood bank. This paper describes the first year of operation from December 1988. Over 5000 units of blood, largely from volunteer donors, were delivered to 19 hospitals. The overall incidence of HIV-1 seropositivity was 14.6% and Hepatitis B surface antigen was 5.5%. The cost was 21.5 ECU (US $25) for each unit of HIV negative, H.B.s.Ag. negative, blood.

Entities:  

Mesh:

Year:  1990        PMID: 10171166     DOI: 10.1016/0955-3886(90)90089-2

Source DB:  PubMed          Journal:  Transfus Sci        ISSN: 0955-3886


  4 in total

1.  The impact of external donor support through the U.S. President's Emergency Plan for AIDS Relief on the cost of red cell concentrate in Namibia, 2004-2011.

Authors:  John P Pitman; Adele Bocking; Robert Wilkinson; Maarten J Postma; Sridhar V Basavaraju; Bjorn von Finckenstein; Mary Mataranyika; Anthony A Marfin; David W Lowrance; Cees Th Smit Sibinga
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

2.  Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey.

Authors:  Josephine Bwogi; Fiona Braka; Issa Makumbi; Vinod Mishra; Barnabas Bakamutumaho; Miriam Nanyunja; Alex Opio; Robert Downing; Benon Biryahwaho; Rosamund F Lewis
Journal:  Afr Health Sci       Date:  2009-06       Impact factor: 0.927

3.  Laboratory costs of a hospital-based blood transfusion service in Malawi.

Authors:  Antonieta Medina Lara; James Kandulu; Laphiod Chisuwo; Andrew Kashoti; Catherine Mundy; Imelda Bates
Journal:  J Clin Pathol       Date:  2007-04-05       Impact factor: 3.411

4.  Antibiotic prophylaxis in the surgical management of miscarriage in low-income countries: a cost-effectiveness analysis of the AIMS trial.

Authors:  Ilias Goranitis; David M Lissauer; Arri Coomarasamy; Amie Wilson; Jane Daniels; Lee Middleton; Jonathan Bishop; Catherine A Hewitt; Andrew D Weeks; Chisale Mhango; Ronald Mataya; Iffat Ahmed; Olufemi T Oladapo; Javier Zamora; Tracy E Roberts
Journal:  Lancet Glob Health       Date:  2019-09       Impact factor: 26.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.